Skip to content
Clinical Trials – home

U 2 Serv Com S.R.L.

Research site

Romania Bl I1 Sc D, Strada Alexandru Cel Bun Nr 6, Ap. 4, 720049 Suceava, Romania

  • 1 trial recruiting
  • Atrial fibrillation · Cardiac failure · Hypertrophic cardiomyopathy
  • Adult patients

About Specializations

U 2 Serv Com S.R.L. in Suceava, Romania specialises in clinical trials of conditions such as Atrial fibrillation, Cardiac failure, Hypertrophic cardiomyopathy, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At U 2 Serv Com S.R.L. in Suceava, the clinical research program is focused on cardiovascular diseases, with studies centered on improving care for people living with heart failure and forms of hypertrophic cardiomyopathy.

  • Research is examining whether new treatment approaches can relieve symptoms and improve daily functioning in patients with symptomatic hypertrophic cardiomyopathy.
  • Trials are also evaluating whether combination therapy may better reduce serious outcomes in heart failure with reduced left ventricular function.
  • The work reflects a strong interest in testing therapies that may improve both symptom control and longer-term cardiovascular outcomes.

This site’s cardiology activity highlights practical clinical questions around treatment effectiveness, safety, and quality of life for patients with complex heart conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Bl I1 Sc D, Strada Alexandru Cel Bun Nr 6, Ap. 4720049 SuceavaRomania
Recruiting now
1 trial
Conditions studied
3

More sites in SuceavaRomania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Cardiac failure

Recruiting

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen Cilag International

Study on Sotagliflozin for Improving Symptoms in Patients with Hypertrophic Cardiomyopathy

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Sotagliflozin
  • Sponsor:Lexicon Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.